Top Biotechnology & Medical Research stocks in United Kingdom

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Market Cap
Price to Earnings
Dividend Yield
gb flag iconGNSGenus£1.65bn34.121.28%
gb flag iconCLINClinigen£1.23bn29.690.59%
gb flag iconERGOErgomed£497.05m29.45n/a
gb flag iconPRTCPuretech Health£491.48mn/an/a
gb flag iconOXBOxford BioMedica£436.17m20.45n/a
gb flag iconAVCTAvacta£276.97mn/an/a
gb flag iconREDXRedx Pharma£223.35mn/an/a
gb flag iconBVXPBioventix£179.72m27.44.41%
gb flag iconSARSareum Holdings£137.84mn/an/a
gb flag iconAGYAllergy Therapeutics£133.63mn/an/a
gb flag iconFARNFaron Pharmaceuticals Oy£118.82mn/an/a
gb flag iconSCLPScancell Holdings£104.96mn/an/a
gb flag iconARECArecor Therapeutics£93.25mn/an/a
gb flag iconETXE-Therapeutics£88.76mn/an/a
gb flag iconFUMFutura Medical£86.84mn/an/a
gb flag iconORPHOpen Orphan£78.83mn/an/a
gb flag iconSNGSynairgen£60.40mn/an/a
gb flag iconC4XDC4X Discovery Holdings£53.53mn/an/a
gb flag icon4BB4Basebio£52.35mn/an/a
gb flag iconYGENYourgene Health£45.44mn/an/a